Real-world data (RWD) has the potential to inform drug development, drug regulation, health technology assessments and to refine clinical guidelines by characterizing a product’s clinical outcomes in more diverse, real-world patient populations. RWD includes data from a variety of sources, including national and regional registries, electronic medical records, claims databases, health surveys and clinical databases. The growth and heterogeneity of available RWD sources has created a data landscape that is increasingly difficult to navigate, and identifying data sources to help answer strategic or study objectives is not always an obvious choice.
Database mapping provides a tool to systematically identify and evaluate RWD sources. This is a flexible methodology that can be customized to meet company needs, whether to locate data sources to answer a specific study question or to get a larger overview of RWD sources for an indication of interest.
Join this webinar to get an overview of database mapping methodology and how it can be leveraged to uncover RWD.
Ekaterina Maslova, ScD, Senior Epidemiologist, Real World Evidence Strategy and Analytics, ICON
Ekaterina Maslova is an epidemiologist with over ten years of experience in epidemiological research and public health, working with large longitudinal data sets of self-reported, clinical and biomarker data as well as national disease and prescription registries in the US, UK and Nordic countries. She has extensive expertise in study design and conceptualization; advanced epidemiologic methods; data collation and analysis; and dissemination into the scientific community. At ICON, Maslova is responsible for designing, leading and analysing observational studies, including retrospective database studies, prospective cohort studies, referral studies and quality improvement studies in a variety of indications.Message Presenter
Ruchika Sharma, BDS, MPH, Analyst II, Real World Evidence Strategy and Analytics, ICON
Ruchika Sharma has over six years of experience encompassing epidemiology, public health and health care. At ICON, Sharma has worked in multiple database mapping and feasibility studies across Europe, North America and Asia-Pacific. She has extensive experience on literature review, disease forecasting techniques, risk-factor modeling, patient-population sizing, epidemiological methods and study design with expertise in analyzing large population-based databases like HCUP, NHANES, SEER and NSSO. Sharma has worked on a variety of therapeutic areas like infectious diseases, neurology, oncology, cardiovascular diseases, metabolic disorders, immunology and respiratory diseases.Message Presenter
Who Should Attend?
This program is intended for professionals from pharmaceutical, biotech and medical device companies involved in:
- Epidemiology, health economics & outcomes research
- Market access
- Medical affairs
What You Will Learn
In this webinar, presenters will:
- Describe what a database mapping is and where it can be useful
- Outline the components of a database mapping and how these can be tailored to meet company objectives
- Demonstrate a use case for database mapping in the field of oncology to identify clinico-genomic databases
ICON plc is a global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specializes in the strategic development, management and analysis of programs that support clinical development. With headquarters in Dublin, Ireland, ICON currently operates from 97 locations in 38 countries and has approximately 13,380 employees. Further information is available at ICONplc.com.